This site requires Javascript.

Please enable Javascript before proceeding:

Firefox

  1. In the FireFox address bar, type about:config.
  2. Look for the javascript.enabled setting.
  3. Set it to true by right-clicking and pressing toggle.

Internet Explorer

  1. On the Tools menu, click Internet Options, then click the Security tab.
  2. Click the Internet Zone.
  3. If you do not have to customize your Internet security settings, click Default Level. Then do step 4.
  4. If you have to customize your Internet security settings, follow these steps:
    a. Click Custom Level.
    b. In the Security Settings - Internet Zone dialog box, click Enable for Active Scripting in the Scripting section.
  5. Click the Back button to return to the previous page, and then click the Refresh button to run scripts.

Chrome

  1. In the Chrome address bar, type chrome://settings/content/javascript.
  2. Adjust the toggle so that javascript is allowed.
  3. Close the Settings tab and Refresh the page.

 

Speakers

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Hocine Abid, MD, MBA | Health Canada

National manager

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Kamaldeep Ajimal, MPharm | MHRA

GCP inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

Scott Appleton, PhD, M.Sc. | Health Canada

Manager

Bureau of Pharmaceutical Sciences (BPS), Pharmaceutical Drugs Directorate (PDD), Health Products and Food Branch (HPFB), Health Canada (HC)

Kassa Ayalew, MD, MPH | FDA

Division Director

Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

B

Alex Basiji, M.Sc. | Health Canada

National Director

Clinical and Border Compliance Programs (CBCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Nahid Bibak, B.Sc. | Health Canada

Compliance and Enforcement Specialist

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Elena Boley, MD, MBA | FDA

Senior Medical Reviewer

Good Clinical Practice Assessment Branch (GCPAB), Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Sherry Bous, PharmD | FDA

Director

Division of Enforcement and Postmarketing Safety (DEPS), Office of Scientific Investigations (OSI), Food and Drug Administration (FDA)

Mandy Budwal-Jagait, M.Sc. | MHRA

Deputy Director

Standards and Compliance, Medicines and Healthcare products Regulatory Agency (MHRA)

David Burrow, PharmD, JD | FDA

Director

Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)

C

Health Canada | TBC

Health Canada | TBC

Seonguen Julia Cho, PhD | FDA

Division Director

Division of Generic Drug Study Integrity (DGDSI), Office of Study Integrity and Surveillance (OSIS), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

D

Arindam Dasgupta, PhD | FDA

Acting Division Director

Division of New Drug Study Integrity (DNDSI), Office of Study Integrity and Surveillance (OSIS), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Anastasia Daskajiannis St John, B.Sc. | MHRA

GPvP inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

E

Anna Edmison, PhD | Health Canada

Senior Clinical Assessment Officer

Bureau of Pharmaceutical Sciences (BPS), Pharmaceutical Drugs Directorate (PDD), Health Products and Food Branch (HPFB), Health Canada (HC)

Jennifer Evans, B.Sc. | Health Canada

Compliance and Enforcement Specialist

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

F

Andrew Fisher, B.Sc. (Hons) | MHRA

Lead Senior GCP Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

Debbi Fox, B.Sc. | Health Canada

Compliance and Enforcement Specialist

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

G

Michelle Gabriel, B.Sc. (Hons), M.Sc. | MHRA

Head of GCP & GCP Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

Kim Godard, PhD | Health Canada

Director General

Health Product Compliance Directorate (HPCD), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Cheryl Grandinetti, PharmD |FDA

Associate director for clinical policy

Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

H

Iram Hassam, PhD | FDA

Reviewer

USPHS Scientist Officer, Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Ricardo J. Hernández, PharmD, MPH | FDA

Pharmacist

Drug Safety Operations (DSO), Office of the Center Director (OCD), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

I

Andrea Ibrahim, M.Sc.| Health Canada

Senior Clinical Evaluator

Office of Clinical Trials (OCT), Pharmaceutical Drugs Directorate (PDD), Health Products and Food Branch (HPFB), Health Canada (HC)

K

Dipti Kalra, RPh, MS, MBA | FDA

Branch Chief

Postmarketing Safety Branch (PSB), Office of Compliance, Food and Drug Administration (FDA)

Sean Kassim, PhD | FDA

Office Director

Office of Study Integrity and Surveillance (OSIS), Office of Translational Sciences (OTS), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Lydia Kim, MD | FDA

Medical reviewer

Good Clinical Practice Assessment Branch (GCPAB), Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Namita Kothary, PharmD, RAC (US) | FDA

Associate Director for Scientific Affairs

Division of Enforcement and Postmarketing Safety (DEPS), Office of Scientific Investigations (OSI), Food and Drug Administration (FDA)

L

Claire Longman, M.Sc. | MHRA

Expert Pharmacovigilance Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

M

Leigh Marcus, MD | FDA

Senior Medical Reviewer

Good Clinical Practice Assessment Branch (GCPAB), Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Michael McGuinness | MHRA

Head of GLP & Laboratories, Head UK GLPMA

Healthcare Quality and Access – Standards & Compliance, Medicines and Healthcare products Regulatory Agency (MHRA)

Rachel Mead, B.Sc. (Hons) | MHRA

Senior GCP Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

Laurie Muldowney, MD | FDA

Deputy Director

Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)

R

Sophie Radicke, M.Sc. | MHRA

Head of GPvP and Senior Pharmacovigilance Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

Ryan Raffaelli, MD | FDA

Team Lead

GCP Compliance Oversight Branch (GCPCOB), Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Shila Rastegar, M.Sc. | Health Canada

Compliance and Enforcement Specialist

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

S

Reza Salehzadeh-Asl, M.Sc. | Health Canada

National supervisor

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Myriam Salem, M.Sc. | Health Canada

National Supervisor

Clinical Trial Compliance Program (CTCP), Regulatory Operations and Enforcement Branch (ROEB), Health Canada (HC)

Jenn W. Sellers, MD, PhD | FDA

Branch chief

GCPAB Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Susan Stojdl, M.Sc. | Health Canada

Senior Clinical Assessment Officer

Bureau of Pharmaceutical Sciences (BPS), Pharmaceutical Drugs Directorate (PDD), Health Products and Food Branch (HPFB), Health Canada (HC)

V

Stephen Vinter, B.Sc. (Hons), CChem FRSC | MHRA

Head of Compliance

Standards and Compliance Team 1, Medicines and Healthcare products Regulatory Agency (MHRA)

W

Jason Wakelin-Smith, B.Sc. (Hons), PGDip | MHRA

Expert GCP Inspector and Head of the Compliance Expert Circle

Medicines and Healthcare products Regulatory Agency (MHRA)

Emma Whale, M.Sc. | MHRA

Senior GCP & GLP Inspector

Medicines and Healthcare products Regulatory Agency (MHRA)

LaKisha Williams, DHA, MSN, PMHNP-BC, CRNP | FDA

Commander (CDR), USPHS GCP International Liaison

Office of Scientific Investigations (OSI), Division of Clinical Compliance Evaluation (DCCE), Office of Compliance (OC), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Z

Regina Zopf, MD, MPH | FDA

Senior Medical Officer

Good Clinical Practice Assessment Branch (GCPAB), Division of Clinical Compliance Evaluation (DCCE), Office of Scientific Investigations (OSI), Center for Drug Evaluation & Research (CDER), Food and Drug Administration (FDA)

Information

Dates: June 2–4, 2026

Times:

Day 1: Tuesday, June 2 | 8:30 AM – 5:15 PM ET
Day 2: Wednesday, June 3 | 8:30 AM – 5:00 PM ET
Day 3: Thursday, June 4 | 8:30 AM - 4:50 PM ET

Event Type: Hybrid event

In-person participation - At Capacity
Virtual - OPEN

Location :

Library and Archives Canada,
395 Wellington St, Ottawa, Ontario, Canada
and Virtual

Cost: Free registration

Contact us

For questions regarding the Symposium contact us at: 2026Symposium@hc-sc.gc.ca